TTYH3 and neoplasm: Subsequently, we analyzed the clinical stages of CRC patients in the Linkedomics database, TTYH3 was chosen as our research focus based on its remarkably higher expression in advanced‐stage tumor tissues (Figure 1C and S1E, F).